294 related articles for article (PubMed ID: 11667936)
1. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
McCormick BB; Tomlinson G; Brill-Edwards P; Detsky AS
JAMA; 2001 Oct 24-31; 286(16):1994-9. PubMed ID: 11667936
[TBL] [Abstract][Full Text] [Related]
2. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
Wofford JL; Ohl CA
BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
[TBL] [Abstract][Full Text] [Related]
3. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
Hodges B
CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
[TBL] [Abstract][Full Text] [Related]
4. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
Zipkin DA; Steinman MA
J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
[TBL] [Abstract][Full Text] [Related]
5. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
[TBL] [Abstract][Full Text] [Related]
6. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
Wang Y; Adelman RA
Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
[TBL] [Abstract][Full Text] [Related]
7. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors.
Lichstein PR; Turner RC; O'Brien K
Arch Intern Med; 1992 May; 152(5):1009-13. PubMed ID: 1580704
[TBL] [Abstract][Full Text] [Related]
8. Changing interactions between physician trainees and the pharmaceutical industry: a national survey.
Austad KE; Avorn J; Franklin JM; Kowal MK; Campbell EG; Kesselheim AS
J Gen Intern Med; 2013 Aug; 28(8):1064-71. PubMed ID: 23444007
[TBL] [Abstract][Full Text] [Related]
9. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.
Hopper JA; Speece MW; Musial JL
J Gen Intern Med; 1997 Oct; 12(10):639-42. PubMed ID: 9346461
[TBL] [Abstract][Full Text] [Related]
10. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.
McKinney WP; Schiedermayer DL; Lurie N; Simpson DE; Goodman JL; Rich EC
JAMA; 1990 Oct; 264(13):1693-7. PubMed ID: 2398609
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical representatives and emergency medicine residents: a national survey.
Reeder M; Dougherty J; White LJ
Ann Emerg Med; 1993 Oct; 22(10):1593-6. PubMed ID: 8214843
[TBL] [Abstract][Full Text] [Related]
12. Physician attitudes toward industry: a view across the specialties.
Korenstein D; Keyhani S; Ross JS
Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
[TBL] [Abstract][Full Text] [Related]
13. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.
Lurie N; Rich EC; Simpson DE; Meyer J; Schiedermayer DL; Goodman JL; McKinney WP
J Gen Intern Med; 1990; 5(3):240-3. PubMed ID: 2341925
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
[TBL] [Abstract][Full Text] [Related]
16. Interactions between emergency medicine programs and the pharmaceutical industry.
Keim SM; Mays MZ; Grant D
Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical industry support and residency education: a survey of internal medicine program directors.
Loertscher LL; Halvorsen AJ; Beasley BW; Holmboe ES; Kolars JC; McDonald FS
Arch Intern Med; 2010 Feb; 170(4):356-62. PubMed ID: 20177039
[TBL] [Abstract][Full Text] [Related]
18. Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.
Yeh JS; Austad KE; Franklin JM; Chimonas S; Campbell EG; Avorn J; Kesselheim AS
J Grad Med Educ; 2015 Dec; 7(4):595-602. PubMed ID: 26692972
[TBL] [Abstract][Full Text] [Related]
19. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
[TBL] [Abstract][Full Text] [Related]
20. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
Alssageer MA; Kowalski SR
Pan Afr Med J; 2013; 14():132. PubMed ID: 23734277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
